FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $9,000 | -98.3% | 1,313 | -97.9% | 0.00% | -100.0% |
| Q4 2015 | $518,000 | -75.1% | 63,926 | -77.5% | 0.00% | -72.7% |
| Q3 2015 | $2,079,000 | -43.8% | 283,589 | -21.4% | 0.01% | -38.9% |
| Q2 2015 | $3,699,000 | +776.5% | 360,785 | +689.6% | 0.02% | +800.0% |
| Q1 2015 | $422,000 | – | 45,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 984,734 | $10,094,000 | 5.25% |
| SENZAR ASSET MANAGEMENT, LLC | 707,449 | $7,251,000 | 1.24% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,133,390 | $11,617,000 | 0.88% |
| Ghost Tree Capital, LLC | 250,000 | $2,563,000 | 0.83% |
| Sio Capital Management, LLC | 161,286 | $1,653,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $3,895,000 | 0.38% |
| Opaleye Management Inc. | 85,000 | $871,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $9,727,000 | 0.32% |
| EAM Investors, LLC | 261,161 | $2,677,000 | 0.31% |
| J. Goldman & Co LP | 405,000 | $4,151,000 | 0.25% |